In an interview, CEO Gerald Pötzsch and CTO Gunnar Läthén discuss how ContextVision’s cutting-edge technology is set to revolutionize medical diagnostics and drive innovation through Data Quality. Watch the interview here: For more information, please contact Gerald Pötzsch Chief…
At the Extraordinary General Meeting of ContextVision AB (publ) held on November 20, 2024, the following decisions were made: Authorization for the Board of Directors to resolve on the acquisition of the company’s own shares The General Meeting resolved in…
The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby invited to the Extraordinary General Meeting on Wednesday, 20 November 2024, at 11:00, at the company's premises, Holländargatan 13, Stockholm. Participation and Notification etc Shareholders who wish to participate…
Adoption of the accounts The Annual General Meeting approved the Company's income statement and balance sheet for 2023. The Board members and the Managing Director were discharged from liability for the fiscal year 2023. Disposition of profits The Annual General…
Notification etc Shareholders who wish to participate in the annual general meeting with the right to vote shall be recorded as shareholder in the share register kept by Euroclear Sweden AB on May 3, 2024, temporary registration for shareholders registered…
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM.…
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding…
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: finance@contextvision.se For inquiries, please contact…
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected…
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…